285979-87-5
285979-87-5
Chemical Structure
Salicylic acid-d6
Synonym(s): 2-Hydroxybenzoic acid-d6
- CAS No.: 285979-87-5
- Formula:C7D6O3
- Molecular Weight:144.16
IUPAC Name: 2-(hydroxy-d)benzoic-d4 acid-d
InChIKey: YGSDEFSMJLZEOE-UDDMDDBKSA-N
SMILES: O=C(O[2H])C1=C(O[2H])C([2H])=C([2H])C([2H])=C1[2H]
Biological Activity: Salicylic acid-d6 is a deuterium labeled Salicylic acid (HY-B0167). Salicylic acid inhibits cyclo-oxygenase-2 (COX-2) activity independently of transcription factor (NF-κB) activation[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Salicylic acid-d6 | 99.82% | Salicylic acid-d6 is a deuterium labeled Salicylic acid (HY-B0167). Salicylic acid inhibits cyclo-oxygenase-2 (COX-2) activity independently of transcription factor (NF-κB) activation. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Salicylic acid (Standard) | 98.00% | Salicylic acid (Standard) is the analytical standard of Salicylic acid. This product is intended for research and analytical applications. Salicylic acid (2-Hydroxybenzoic acid) inhibits cyclo-oxygenase-2 (COX-2) activity independently of transcription factor (NF-κB) activation. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
2-Carboxyphenol-d4 | 99.83% | 2-Carboxyphenol-d4 is the deuterium labeled 2-Carboxyphenol. 2-Carboxyphenol is a plant hormone and mediates host responses against microbial pathogens. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Salicylic acid-13C6 | 97.0% | Salicylic acid-13C6 is the 13C-labeled Salicylic acid (HY-B0167). Salicylic acid is a precursor to and a metabolite of Aspirin (HY-14654), can inhibit cyclo-oxygenase-2 (COX-2) activity. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Salicylic acid | 98.42% | Salicylic acid (2-Hydroxybenzoic acid) inhibits cyclo-oxygenase-2 (COX-2) activity independently of transcription factor (NF-κB) activation. Salicylic acid has blood-brain barrier permeability. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
